Excelsyn was announced Winner of the Welsh Exporter of the Year Award, sponsored by International Business Wales, at the Daily Post's Achievement Wales 2007 Business Awards on Friday 30th November.

Pharma and biotech services company, Excelsyn, has announced the appointment of Dr. Reg Shaw BSc, PhD as Non Executive Director.

Pharma and biotech services company, Excelsyn, has announced the appointment of CHEMGO Organica AG as its exclusive representative in the Swiss market.

Pharma intermediate and ingredient producers Excelsyn Molecular Development, of Holywell UK, has received a £350k Dti Spring Innovation Award to fund continuing research into new, high efficiency production routes for the synthesis of new pharmaceutical intermediates in collaboration with Bangor University, North Wales, UK.

Excelsyn Group Chairman and CEO Ian Shott has been named as Chemistry World Entrepreneur of the Year 2006 by the Royal Society of Chemistry (RSC).

Pharmaceutical and biotechnology services group Excelsyn has laid the foundations for further rapid growth through a co-investment by the private equity and buyout fund Endless LLP ("Endless") and the North East England-based fund NorthStar Equity Investors Ltd. ("NorthStar").

Pharmaceutical services group Excelsyn has today (14 February 2007) announced a major package of new developments for its UK-based pharma synthesis business Excelsyn Molecular Developments.

Pharmaceutical and biotech services group Excelsyn has appointed consultant Anne Baker, MA CIPD, to act as Group Human Resources Manager.

Excelsyn Engineering Technology has marked the formal opening of new and larger offices and workshops in Newburn Riverside, Newcastle-upon-Tyne.

The Excelsyn pharmaceutical services group has become the latest major player in the sector to join the Britest Ltd.